Dietary and pharmaceutical compositions for management and treatment of oxidative stress
OwnerRita Ellithorpe, Vladimir Slesarev +1inventors
InventorsRita Ellithorpe, Vladimir Slesarev, Todor Dimitrov
Life of this patent
Estimating the term…
Abstract
Inhibition of TNF alpha prooxidant action is achieved after administration of biodegradable N-Acetyl-glucosamine-N-acetyl-muramyl-peptides released after specific endopeptidase and lysozyme digestion of the genus Lactobacillus and Bifidum. This invention also provides a medical food for dietary management of all conditions with elevated Gamma Glutamyl Transferase activity and concurrent alterations of NF-κB expression, which may be particularly useful for apoptosis modulation in people with chronic viral infection and cancer metastasis.
Claims20
A method of reduction of oxidative stress under all conditions with elevated gamma glutamyl transferase and NF-κB in humans and domestically useful animals with concurrent enhancement of apoptosis of cancer cells and cells infected with RNA virus, comprising the administration of therapeutically effective amount 10-5000 mg glucosaminemuramyl peptides.
A method of dietary management of disease state with elevated gamma glutamyl transferase by feeding humans and domestically useful animals with predigested antioxidant food, comprising administration a therapeutically effective amount of N-acetyl-glucosaminemuramyl peptides, bioflavonoids, papaya, and sea urchin.
A method of claim 3 where a disease state is caused by liver, brain and lung metastasis metastasis of colorectal, ovarian and breast carcinoma
A method of dietary management of anemia, thrombocytopenia, and leucopenia by feeding humans and domestically useful animals with therapeutically effective amount of N-acetyl-glucosamine-N-acetyl-muramyl-L-alanine,D-isoglutamine-L-lysine-D-alanine.
Dependencies are inferred from the claim text.